STERIS plc (STE) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.042x

Based on the latest financial reports, STERIS plc (STE) has a cash flow conversion efficiency ratio of 0.042x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($298.20 Million) by net assets ($7.17 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See STERIS plc net asset quality index to measure how much of total assets are equity-financed.

STERIS plc - Cash Flow Conversion Efficiency Trend (1991–2025)

This chart illustrates how STERIS plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check STE cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

STERIS plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of STERIS plc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
SBI Life Insurance Company Limited
NSE:SBILIFE
0.764x
FUJIFILM HDGS CORP. ADR 1
F:FJIA
N/A
US Foods Holding Corp
NYSE:USFD
0.068x
Roivant Sciences Ltd
NASDAQ:ROIV
-0.040x
Bank of Nanjing Co Ltd
SHG:601009
0.153x
Formosa Petrochemical Corp
TW:6505
0.052x
BOUYGUES UNSP.ADR 1/5/EO1
F:BYG0
0.242x
BE SEMICON.INDS NY EO091
F:BSIA
0.115x

Annual Cash Flow Conversion Efficiency for STERIS plc (1991–2025)

The table below shows the annual cash flow conversion efficiency of STERIS plc from 1991 to 2025. For the full company profile with market capitalisation and key ratios, see how much is STERIS plc worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 $6.62 Billion $1.15 Billion 0.174x +12.60%
2024-03-31 $6.32 Billion $973.27 Million 0.154x +23.93%
2023-03-31 $6.09 Billion $756.95 Million 0.124x +18.84%
2022-03-31 $6.54 Billion $684.81 Million 0.105x -40.96%
2021-03-31 $3.89 Billion $689.64 Million 0.177x +2.23%
2020-03-31 $3.41 Billion $590.56 Million 0.173x +2.36%
2019-03-31 $3.19 Billion $539.50 Million 0.169x +19.06%
2018-03-31 $3.22 Billion $457.63 Million 0.142x -5.75%
2017-03-31 $2.81 Billion $424.09 Million 0.151x +80.08%
2016-03-31 $3.04 Billion $254.68 Million 0.084x -63.43%
2015-03-31 $1.07 Billion $246.04 Million 0.229x +13.83%
2014-03-31 $1.04 Billion $209.63 Million 0.201x -16.31%
2013-03-31 $946.98 Million $227.81 Million 0.241x +32.49%
2012-03-31 $822.66 Million $149.37 Million 0.182x +21.62%
2011-03-31 $788.66 Million $117.74 Million 0.149x -49.93%
2010-03-31 $754.49 Million $224.95 Million 0.298x +27.85%
2009-03-31 $717.74 Million $167.38 Million 0.233x +14.89%
2008-03-31 $706.48 Million $143.40 Million 0.203x +64.16%
2007-03-31 $774.29 Million $95.74 Million 0.124x -44.20%
2006-03-31 $730.83 Million $161.96 Million 0.222x +12.49%
2005-03-31 $755.64 Million $148.87 Million 0.197x +3.60%
2004-03-31 $679.06 Million $129.13 Million 0.190x -18.75%
2003-03-31 $569.53 Million $133.29 Million 0.234x -19.72%
2002-03-31 $487.14 Million $142.02 Million 0.292x +20.90%
2001-03-31 $424.38 Million $102.34 Million 0.241x +42.81%
2000-03-31 $421.09 Million $71.11 Million 0.169x +14.12%
1999-03-31 $435.90 Million $64.50 Million 0.148x +342.62%
1998-03-31 $358.95 Million $12.00 Million 0.033x -39.56%
1997-03-31 $294.70 Million $16.30 Million 0.055x -75.90%
1996-03-31 $304.10 Million $69.80 Million 0.230x -85.08%
1995-03-31 $44.60 Million $68.60 Million 1.538x +1766.96%
1994-03-31 $35.20 Million $2.90 Million 0.082x +216.60%
1993-03-31 $26.90 Million $700.00K 0.026x +108.62%
1992-03-31 $5.30 Million $-1.60 Million -0.302x -50.94%
1991-03-31 $1.50 Million $-300.00K -0.200x --

About STERIS plc

NYSE:STE USA Medical Devices
Market Cap
$22.82 Billion
Market Cap Rank
#1266 Global
#527 in USA
Share Price
$232.71
Change (1 day)
-0.06%
52-Week Range
$199.40 - $268.65
All Time High
$268.65
About

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital … Read more